Stockscreener 앱 받기
11.99
3.31%
-0.41
시간 외 거래:
11.92
-0.07
-0.58%
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Repligen (RGEN) and CareDx (CDNA) - The Globe and Mail
FDA clears Delcath’s Phase 2 trial for breast cancer treatment By Investing.com - Investing.com South Africa
FDA clears Delcath’s Phase 2 trial for breast cancer treatment - Investing.com Australia
Delcath Systems Gets FDA Clearance to Start Phase 2 Trial of Hepzato for Metastatic Breast Cancer - marketscreener.com
Delcath Systems (DCTH) Cleared by FDA to Start Phase 2 Trial for Hepzato | DCTH Stock News - GuruFocus
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
FDA Green Lights Delcath's Breakthrough Liver Cancer Tech Expansion into Breast Cancer Market - Stock Titan
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - The Joplin Globe
Geode Capital Management LLC Buys 37,056 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Financial Metrics Unveiled: Delcath Systems Inc (DCTH)’s Key Ratios in the Spotlight - DWinneX
Delcath Systems Inc (DCTH) shows promising results - uspostnews.com
Liver Cancer Treatment Leader Delcath Systems to Report Q1 2025 Earnings May 8 - Stock Titan
(DCTH) Proactive Strategies - news.stocktradersdaily.com
Moffitt-Led International Study Finds New Drug Delivery System Effective Against Rare Eye Cancer - Central Florida Health News
Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? - Nasdaq
Delcath Systems Announces Publication of Comparative Analysis fr - GuruFocus
Clinical Data: Delcath's Melanoma Treatment Achieves 175% Better Survival Than Standard Care - Stock Titan
How To Trade (DCTH) - news.stocktradersdaily.com
Pheochromocytoma Treatment Market Size in 7MM is expected - openPR.com
Hospitals Experience FOMO In Adopting Delcath’s PHP Treatment (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems, Inc. (NASDAQ:DCTH) Is Expected To Breakeven In The Near Future - simplywall.st
Charles Schwab Investment Management Inc. Invests $156,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
5,470 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Quantbot Technologies LP - Defense World
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Jim Cramer Blesses Delcath Systems (DCTH): ‘You’re Not Early, But It’s a Win’ - MSN
Jim Cramer Discussed These 6 Stocks Recently - Insider Monkey
Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? - MSN
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Lelezard
Liver Cancer Treatment Breakthrough? Delcath to Reveal Latest Advances at Major Oncology Conference - Stock Titan
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN
Delcath Systems awards stock options to new employees By Investing.com - Investing.com Australia
Delcath Systems awards stock options to new employees - Investing.com India
Delcath Systems Strengthens Workforce: 264,000 Stock Options Granted to New Strategic Hires - StockTitan
Delcath Systems Reports Strong 2024 Financial Growth - TipRanks
With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St
Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks
HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks
Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India
11.62%
0.20%
자본화:
|
볼륨(24시간):